Solstice Oncology
Why now
Where Solstice Oncology is today
Solstice Oncology announced a Series A round of $225M on 9 September 2026, led by RA Capital Management.
Momentum AfterRaise intelligence
AfterRaise Score
- Hiring momentum Open roles and hiring pace
- Market expansion New offices and new countries
- Leadership Executive appointments
- Product activity Launches and releases
In their own words
What Solstice Oncology says it is doing
Public signal Described in the funding announcement as "immuno-oncology company focused on treating cancer earlier in the neoadjuvant setting". Source
Public signal Read from the company's own description of what the funding supports.
Since the raise
What has happened since
- 9 September 2026$225M Series ALed by RA Capital Management.
Public signal The timeline currently holds funding events, because those are the signals AfterRaise observes today. Hiring, leadership, expansion and product events join it with the signals layer.
What may happen next
What this raise could create
What may happen next
- Research programme expansion
- Scientific team growth
- Aggressive multi-front expansion
- Senior executive hiring
Opportunities this could create
- Clinical operations
- Scientific hiring
- Scientific advisers
- Research operations
- Specialist suppliers
Based on the Biotech & Pharma sector, a Series A round and the priorities the company itself set out. Not a statement of fact.
- 9 September 2026$225M Series A announced
- 9 September 2026Stated priority: research and development
High momentum means several meaningful company changes have occurred in a short period. Signals here are funding events and the priorities the company stated; hiring, leadership and expansion detection join with the signals layer.
Open to
What Solstice Oncology is open to
Not yet specified
Solstice Oncology has not told AfterRaise which approaches it welcomes. Until it does, we do not assume. Offers to help are held and shown to the company, and the company decides whether to open a conversation.
Work here? Set your preferencesOpportunities
Ways to work with Solstice Oncology
No open opportunities listed
Jobs, projects, partnerships, advisory and supplier needs appear here once the company has claimed its page and published them, and any role we read from its own job board appears automatically.
Work here? Open the first oneHelpful contributors
People who have contributed here
Nobody yet
When someone offers help and the company says it was useful, they appear here. Reputation on AfterRaise is built from contributions the company confirmed, not from follower counts.
Do you work at Solstice Oncology?
Reserve your company page.
This page was created from publicly available information. When verified company accounts open, your team will be able to correct your profile, tell the market what you actually need and control how people approach you.
What we do not have yet: the roles and projects you have open. Claiming the page is how you fill those in.
Someone else requesting access does not give them ownership. Every company administrator is verified before access is granted.
The first 1,000 verified funded companies join the Founding 1,000 free for life and keep Founding Company status permanently.
Also moving